Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
China's National Medical Products Administration (NMPA)
Manufacturing
Sun Pharma's dementia med suspended in China after inspection
China’s drug regulator has suspended the import, sale and use of Sun's rivastigmine hydrogen tartrate capsules after a subpar production inspection.
Zoey Becker
Jan 27, 2026 11:47am
Padcev-Keytruda result, Alzheimer's med, Fosun—Fierce Pharma Asia
Aug 15, 2025 8:31am
China did not renew approval of controversial Alzheimer's drug
Aug 14, 2025 11:22am
China approves 4 new drugs, including global 1st-in-class
Jul 2, 2025 11:32am
Lilly, Innovent's mazdutide nabs first-in-class nod in China
Jun 27, 2025 11:16am
Eisai, ex-NMPA official, Pfizer-Summit—Fierce Pharma Asia
Feb 28, 2025 8:45am
